(Total Views: 441)
Posted On: 02/22/2021 7:55:21 AM
Post# of 148908
Facts about the PR info:
- Has the data been unblinded and distributed to US, UK and Canada regulators? YES ... very good news, removes some doubts.
- Discussions are “ongoing” with all three agencies in parallel? Points to NP strategy to ensure no FDA bottling of our results? Unusual but due to interest being very high, he can execute this. First agency that bites get’s the drugs?
- Schedule for outcome 2-3 weeks? PR sounded like he was eager to share the outcome but there are major commercial stakes at play and he does not want to accidentally screw it up. WISE MOVE!
- Has the data been unblinded and distributed to US, UK and Canada regulators? YES ... very good news, removes some doubts.
- Discussions are “ongoing” with all three agencies in parallel? Points to NP strategy to ensure no FDA bottling of our results? Unusual but due to interest being very high, he can execute this. First agency that bites get’s the drugs?
- Schedule for outcome 2-3 weeks? PR sounded like he was eager to share the outcome but there are major commercial stakes at play and he does not want to accidentally screw it up. WISE MOVE!
(14)
(0)Scroll down for more posts ▼
